Cazorla, L.; Alaux, S.; Amberger, C.; Mabilais, C.; Furtado, L.; Buchard, A.; Thorens, G.; Penzenstadler, L.; Zullino, D.; Aboulafia Brakha, T.
Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder. Psychoactives 2025, 4, 26.
https://doi.org/10.3390/psychoactives4030026
AMA Style
Cazorla L, Alaux S, Amberger C, Mabilais C, Furtado L, Buchard A, Thorens G, Penzenstadler L, Zullino D, Aboulafia Brakha T.
Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder. Psychoactives. 2025; 4(3):26.
https://doi.org/10.3390/psychoactives4030026
Chicago/Turabian Style
Cazorla, Laure, Sylvie Alaux, Caroline Amberger, Cédric Mabilais, Leonice Furtado, Albert Buchard, Gabriel Thorens, Louise Penzenstadler, Daniele Zullino, and Tatiana Aboulafia Brakha.
2025. "Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder" Psychoactives 4, no. 3: 26.
https://doi.org/10.3390/psychoactives4030026
APA Style
Cazorla, L., Alaux, S., Amberger, C., Mabilais, C., Furtado, L., Buchard, A., Thorens, G., Penzenstadler, L., Zullino, D., & Aboulafia Brakha, T.
(2025). Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder. Psychoactives, 4(3), 26.
https://doi.org/10.3390/psychoactives4030026
